Build a lasting personal brand

Six Peptide Compounds Lead Laboratory Research in 2026, According to cheat codes Review

A review by cheat codes identifies BPC-157, TB-500, CJC-1295, Ipamorelin, Selank, and Epithalon as the most studied peptides in peer-reviewed literature, with implications for preclinical research directions.

Found this article helpful?

Share it with your network and spread the knowledge!

Six Peptide Compounds Lead Laboratory Research in 2026, According to cheat codes Review

A research review published by cheat codes has ranked six peptide compounds as the most studied in peer-reviewed literature as of 2026, based on biochemical profiles, citation volume, and documented in vitro or in vivo outcomes. The review aims to guide laboratory researchers in sourcing research peptides for preclinical studies, as demand for reproducible peptide data continues to shape procurement decisions.

The six compounds covered include BPC-157, TB-500, CJC-1295, Ipamorelin, Selank, and Epithalon. BPC-157, a 15-amino acid sequence derived from a protective gastric protein, has been studied for over two decades in animal models, with documented findings in tendon-to-bone healing and nitric oxide pathway modulation. A frequently cited 2019 study in the Journal of Physiology - Paris recorded accelerated Achilles tendon repair in rat models.

TB-500, or Thymosin Beta-4, is a 43-amino acid peptide involved in actin sequestration and cell migration. In vitro studies have identified its role in endothelial cell proliferation, while a 2016 publication in the Annals of the New York Academy of Sciences documented its involvement in cardiac tissue repair following ischemic events in animal models.

CJC-1295, a synthetic analogue of growth hormone-releasing hormone (GHRH) modified with drug affinity complex (DAC) technology, has demonstrated sustained growth hormone elevation over six days in animal and early-phase human cell studies, according to a 2006 paper in the Journal of Clinical Endocrinology & Metabolism. Ipamorelin, a selective growth hormone secretagogue, shows minimal cross-reactivity with cortisol or prolactin pathways, as noted in a 1998 study in the European Journal of Endocrinology.

Selank, a heptapeptide analogue of tuftsin, has been studied for its effects on GABA-A receptor modulation and interleukin-6 expression, with over 30 peer-reviewed studies indexed in international databases as of 2024. Epithalon, a synthetic tetrapeptide derived from the pineal peptide epithalamin, has been investigated for telomerase activation, with a 2003 study in Neuroendocrinology Letters reporting telomere elongation in human somatic cell cultures.

The review draws exclusively from indexed peer-reviewed publications, in vitro assay data, and documented in vivo animal model outcomes, excluding anecdotal or commercial sources. "This review covers six peptide compounds with a combined peer-reviewed citation record spanning more than 25 years of published science," said Dr. Marcus Hale, Director of Research Curation at cheat codes. "The intent is to give laboratory researchers a consolidated reference point grounded entirely in documented in vitro and in vivo data."

All six compounds are available for laboratory procurement through Cheat Codes Peptides, which supplies catalogued peptide compounds strictly for research use. The full review and compound specifications are accessible through the cheat codes research library.

Burstable Editorial Team

Burstable Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.